Gennate Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Gennate Ltd - overview
Established
2022
Location
London, -, UK
Primary Industry
Materials
About
Gennate Ltd, based in the UK, specializes in innovative nanotechnology solutions that enhance agricultural productivity and sustainability through effective micronutrient formulations. Gennate Ltd is a London-based company founded in 2022 that focuses on developing nano-technology solutions for agriculture. The company has maintained a consistent business strategy without pivots or changes. It raised GBP 550,000 in Seed funding on March 23, 2026, led by SFC Capital with investors including Greater Manchester Combined Authority.
Gennate has completed 1 deal and raised a total of GBP 550,000 in funding to date. Gennate is dedicated to providing innovative nano-technology solutions geared towards enhancing agricultural productivity and sustainability. Its product range includes a generic nano formula of micronutrients applicable to all plant types, as well as tailored formulations for small herbs, vegetables, seed treatments, and vertical farming systems. These products enhance crop quality, yield, and farming efficiency by ensuring optimal micronutrient absorption and utilization, catering to various stakeholders, such as farmers and agricultural retailers across Europe, North America, and select Asian markets.
Gennate generates revenue through direct sales of its nano-formulated products to agricultural businesses and growers. Operating primarily on a B2B model, clients include large-scale farms and agricultural cooperatives that purchase products in bulk. The pricing for Gennate's flagship products, including NanoGrow™ and NanoGrowVeg™, is structured to reflect the value added in terms of crop enhancement and sustainability initiatives. In March 2026, Gennate Ltd raised GBP 550,000 in Seed funding to advance its transition from laboratory-stage development to pilot-scale manufacturing.
The company plans to create up to 15 new jobs over the next three years, focusing on technology maturation, fabrication, and initial industrial pilots with agritech partners. Gennate aims to expand its product line with new nano-technology solutions and penetrate additional markets in Europe and Asia by 2027.
Current Investors
Greater Manchester Combined Authority, SFC Capital
Primary Industry
Materials
Sub Industries
Agribusiness, Nanomaterials
Website
www.gennate.com/
Verticals
Agtech, Research (Non-Medical)
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.